As Summit Therapeutics’ Chinese partner prepares to reveal data for a key trial at ASCO, analysts consider the impact on rivals Merck, Bristol Myers Squibb and BioNTech.
Hosted on MSN
When SSRIs fail: The neuromodulation pathway
Selective serotonin reuptake inhibitors (SSRIs) are considered the first-line, gold standard treatment for depression. However, their use is not without limitations, with commonly reported side ...
The latest testing follows encouragement from President Trump himself for the VA to explore different modalities to treat ...
Abstract: Drone-based rapid and accurate environmental edge detection is highly advantageous for tasks such as disaster relief and autonomous navigation. Current methods, using radars or cameras, ...
ABSTRACT: The present study aimed to investigate the relationship between metamemory, metacognition, and academic vitality with academic procrastination among students. This research was applied in ...
Abstract: Learning academic content in a second language (L2) depends on how content domain, presentation modality, and linguistic complexity jointly shape cognitive and motivational states. Using a ...
Finally, some good news: More and more people are getting active, according to the Sports and Fitness Industry Association’s (SFIA) recent report. For the first time since they started tracking ...
ABSTRACT: Cardiac rehabilitation helps improve the prognosis and quality of life for patients with heart disease. To show its interest in the African context, in the management of heart disease, a ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. You are free to share(copy and redistribute) this ...
Multiple myeloma still appears to be an incurable hematological malignancy. One of the reasons is that myeloma cells can be heterogenous and acquire resistance after anti-myeloma treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results